As of Q4'25 (2025-12-28), Johnson & Johnson ( JNJ ) reported an EPS of 2.03 USD, with year-over-year EPS growth at 0.43%. This marks a moderate increase from the previous quarter's EPS of 2.14 USD, indicating relative stability in recent performance. From Q1'23 to Q4'25, the EPS trend for JNJ has been volatile, with notable fluctuations including a sharp spike to 10.32 USD in Q3'23 and a significant drop to -0.03 USD in Q1'23. The YoY EPS growth rate also showed considerable swings, peaking at 46% in Q1'24 and dipping to -101.53% in Q1'23. Overall, while the EPS has stabilized around the 2 USD mark in the last few quarters, the period is characterized by high variability and several pronounced inflection points.